Patricia M. Danzon
Affiliations: | Health Care Management & Economics | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Health Care Management, General EconomicsGoogle:
"Patricia Danzon"Children
Sign in to add traineeLi-Wei Chao | grad student | 2002 | Penn |
Jonathan D. Ketcham | grad student | 2002 | Penn |
Michael F. Furukawa | grad student | 2005 | Penn |
Gilbert W. Gimm | grad student | 2005 | Penn |
Nuno Sousa Pereira | grad student | 2006 | Penn |
Eric L. Keuffel | grad student | 2010 | Penn |
Andrew Mulcahy | grad student | 2011 | Penn |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Danzon PM. (2019) Drug Pricing and Value in Oncology. Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer. 213: 153-167 |
Danzon PM. (2018) Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. Pharmacoeconomics |
Danzon PM. (2018) Affordability Challenges to Value-Based Pricing: Mass Diseases, Orphan Diseases, and Cures. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 252-257 |
Garrison LP, Neumann PJ, Willke RJ, et al. (2018) A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 161-165 |
Phelps CE, Lakdawalla DN, Basu A, et al. (2018) Approaches to Aggregation and Decision Making-A Health Economics Approach: An ISPOR Special Task Force Report [5]. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 146-154 |
Danzon PM, Drummond MF, Towse A, et al. (2018) Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4]. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 140-145 |
Lakdawalla DN, Doshi JA, Garrison LP, et al. (2018) Defining Elements of Value in Health Care-A Health Economics Approach: An ISPOR Special Task Force Report [3]. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 131-139 |
Danzon PM, Towse AK, Mestre-Ferrandiz J. (2015) Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context Health Economics. 24: 294-301 |
Danzon PM, Mulcahy AW, Towse AK. (2015) Pharmaceutical pricing in emerging markets: effects of income, competition, and procurement. Health Economics. 24: 238-52 |
Danzon PM. (2015) Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? International Journal of the Economics of Business. 22: 245-261 |